SLC39A12: A Protein Involved in Cell Signaling, DNA Replication and Growth

Target Name: SLC39A12

NCBI ID: G221074

SLC39A12

SLC39A12: A Protein Involved in Cell Signaling, DNA Replication and Growth

SLC39A12 is a protein that belongs to the SLC39 family, which is a well-known transmembrane protein family that plays a crucial role in the transport of various molecules across cell membranes. SLC39A12 is a member of the SLC39A12 subfamily, which is characterized by the presence of a unique transmembrane region that is composed of a long amino acid sequence known as the SLC39A12Zn transmembrane domain.

The SLC39A12Zn transmembrane domain is a type of zinc transporter that is involved in the transport of zinc ions across the cell membrane. Zinc ions are essential for a wide range of biological processes, including cell signaling, DNA replication, and cell growth. The SLC39A12Zn transmembrane domain is able to facilitate the transport of zinc ions across the cell membrane, which is a critical function for the protein.

SLC39A12 is also involved in the regulation of cellular signaling pathways. In particular, SLC39A12 has been shown to be involved in the regulation of the production of reactive oxygen species (ROS), which are highly reactive molecules that can cause damage to cellular components if they are not properly regulated. SLC39A12 has been shown to play a role in the production of ROS by promoting the production of reactive oxygen species, which can then react with other cellular components to generate reactive oxygen species intermediates.

In addition to its role in cellular signaling pathways, SLC39A12 is also a potential drug target. SLC39A12 has been shown to be involved in a wide range of cellular processes, including cell signaling, DNA replication, and cell growth. As a result, SLC39A12 is a potential drug target for a wide range of diseases, including neurodegenerative disorders, cancer, and cardiovascular disease.

SLC39A12 has also been shown to be involved in the regulation of cellular replication. In particular, SLC39A12 has been shown to play a role in the regulation of DNA replication, which is a critical process for the development and maintenance of cellular organisms. SLC39A12 has been shown to promote the production of DNA replication factors, which are proteins that are involved in the regulation of DNA replication, and it has also been shown to prevent the formation of DNA replication factors that are associated with the development of cancer.

In conclusion, SLC39A12 is a protein that is involved in a wide range of cellular processes, including cell signaling, DNA replication, and cell growth. SLC39A12 is also a potential drug target, due to its involvement in the regulation of cellular signaling pathways, DNA replication, and cell growth. Further research is needed to fully understand the role of SLC39A12 in cellular processes and to develop potential drugs that can target this protein.

Protein Name: Solute Carrier Family 39 Member 12

Functions: Uniporter that promotes Zn(2+) import from the extracellular space to the cytoplasm across the cell membrane. The transport activity is temperature dependent. May play a role in neurulation and neurite extension. May play a key role in maintaining intracellular zinc content at levels that reduce the inhibitory effects of rises in oxidative stress on spermatogonia and spermatozoa viability during spermatogenesis

The "SLC39A12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC39A12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets